{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:47:37Z","timestamp":1781880457811,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T09:47:47Z","timestamp":1640252867000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Radiotherapy for cancers of the oesophagus, cardia and stomach"],"prefix":"10.1016","volume":"26","author":[{"given":"G.","family":"Cr\u00e9hange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Qu\u00e9ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"R\u00e9tif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.11.022_bib0115","series-title":"Th\u00e9saurus national de canc\u00e9rologie digestive\u00ae","article-title":"Cancer de l\u2019\u0153sophage","author":"Lledo","year":"2016"},{"key":"10.1016\/j.canrad.2021.11.022_bib0120","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ejca.2015.07.026","article-title":"Survival for oesophageal, stomach and small intestine cancers in Europe 1999\u20132007: results from EUROCARE-5","volume":"51","author":"Anderson","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.11.022_bib0125","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0130","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.11.022_bib0135","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.11.022_bib0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with folfox versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.11.022_bib0150","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2021.11.022_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2004.10.001","article-title":"Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?","volume":"73","author":"Vrieze","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijrobp.2009.08.026","article-title":"Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors","volume":"77","author":"Bouchard","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.022_bib0165","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.radonc.2015.09.006","article-title":"The influence of gastric filling instructions on dose delivery in patients with oesophageal cancer: a prospective study","volume":"117","author":"Van De Voorde","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2009.03.018","article-title":"EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach","volume":"92","author":"Matzinger","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.radonc.2016.01.005","article-title":"Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography","volume":"118","author":"Jin","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijrobp.2006.09.054","article-title":"Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration","volume":"67","author":"Dieleman","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.022_bib0185","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0190","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2012.02.015","article-title":"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy for esophageal cancer","volume":"84","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.022_bib0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jtho.2016.10.013","article-title":"Local control and toxicity of a simultaneous integrated boost for dose escalation in locally advanced esophageal cancer: interim results from a prospective phase I\/II trial","volume":"12","author":"Welsh","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jamaoncol.2019.6412","article-title":"Using real-world historical controls to evaluate radiation dose escalation in esophageal cancer-Reply","volume":"6","author":"Chen","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0205","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jamaoncol.2019.2809","article-title":"Results of a phase 1\/2 trial of chemoradiotherapy with simultaneous integrated boost of radiotherapy dose in unresectable locally advanced esophageal cancer","volume":"5","author":"Chen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2014.12.007","article-title":"Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18F)-FDG-PET\/CT for esophageal cancer","volume":"114","author":"Yu","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.022_bib0215","article-title":"Organs at risk radiation dose constraints","volume":"26","author":"No\u00ebl","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2021.11.022_bib0220","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821003127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821003127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:37:32Z","timestamp":1761136652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821003127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821003127"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.022","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for cancers of the oesophagus, cardia and stomach","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}